Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.140
-1.160-3.29%
Volume:15.59M
Turnover:537.10M
Market Cap:207.02B
PE:31.37
High:34.660
Open:34.480
Low:33.640
Close:35.300
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.98
T/O Rate:0.26%
Dividend:0.50
Dividend Rate:1.45%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.68
PE(LYR):31.37
PS:11.13

Loading ...

GSK Q2 Sales Beat Analyst Estimates on Specialty Medicines Growth

Reuters
·
Jul 28

GSK, Hansoh's Cancer Drug Meets Main Goal of Bone Cancer Trial

Reuters
·
Jul 28

Hansoh Pharma's HS-20093 Achieves Primary Goal in Phase III Osteosarcoma Study

Stock News
·
Jul 28

Hansoh Pharma Says Artemis-011 Phase 3 Trial of Hs-20093 Meets Primary PFS Endpoint in Osteosarcoma

Reuters
·
Jul 28

Hansoh Pharmaceutical - to Initiate Biologics License Application Process in China in the Near Term

THOMSON REUTERS
·
Jul 28

Hansoh Pharmaceutical - Phase Iii Clinical Study of Hs-20093 in Treatment- of Osteosarcoma Has Met Primary Endpoint

THOMSON REUTERS
·
Jul 28

CLSA Maintains Positive Rating on Hansoh Pharma, Raises Price Target to HK$42

Deep News
·
Jul 28

Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$37.24 From HK$38, Keeps at Neutral

MT Newswires Live
·
Jul 27

Oral Cyclic Peptides Enter Validation Phase, Opening a Multi-Billion Dollar Therapeutic Arena

Stock News
·
Jul 22

Hansoh Pharmaceutical Group Stock Slips 1.5% in Hong Kong

Dow Jones
·
Jul 21

Movement Alert|Hansoh Pharmaceutical Declines 3.33% in Regular Trading, Trading at HK$31.98

Market Focus
·
Jul 21

Hansoh Pharmaceutical Group Stock Rises 4.0% in Hong Kong

Dow Jones
·
Jul 20

Movement Alert|Hansoh Pharmaceutical Rises 3.08% in Regular Trading, Pharmaceutical Sector Recovery Coupled with Multiple Pipeline Catalysts

Market Focus
·
Jul 20

Hansoh Pharmaceutical Group Stock Falls 4.1% in Hong Kong

Dow Jones
·
Jul 17

Movement Alert|Hansoh Pharmaceutical Falls 3.08% in Regular Trading, Broad Pharmaceutical Sector Weakness Drags Shares Lower

Market Focus
·
Jul 17

Movement Alert|Hansoh Pharmaceutical Rises 3.17% in Regular Trading, Multiple Catalysts Including Avere-NextCure Merger and HS-20093 Phase III Success Drive Momentum

Market Focus
·
Jul 16

Hansoh Pharma Earns MSCI ESG AAA Rating

Reuters
·
Jul 15

HANSOH PHARMA Shares Surge on Global Licensing Deal and Merger Announcement

Stock News
·
Jul 15

Movement Alert|Hansoh Pharmaceutical Rises 3.5% in Regular Trading, Subsidiary Avere to Merge into Nasdaq-Listed NextCure

Market Focus
·
Jul 15

Hansoh Pharmaceutical Discloses Transactions with Avere Therapeutics

Reuters
·
Jul 14